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1406 Abstracts November 2014and 37.5% were women. The preintervention and postintervention patient
risk factor proﬁle is presented in the Table. Medication usage and risk factor
control improved at follow-up, except for diabetic glycemic control.
Conclusions: The strategy of providing PAD patients and their phy-
sicians with a one-time, individualized plan for risk factor modiﬁcation im-
proves risk factor control. Other studies have reported minimal
improvement in risk factor control with usual medical care or another inter-
vention, although the literature is limited and based on short-term follow-
up. The impact on cardiovascular events and limb outcomes remains to
be determined.
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Google Maps Offers a New Way to Assess for Claudication
Husain Khambati, Prassad Jetty. Department of Vascular Surgery, The
Ottawa Hospital, Civic Campus, Ottawa, Ontario, Canada
Objectives: Accurate determination of walking capacity, speciﬁcally,
maximal walking distance (MWD), is important for the clinical diagnosis
and management plan for patients with peripheral arterial disease. The cur-
rent gold standard for measuring MWD is walking distance on a treadmill.
However, treadmill testing is neither reﬂective of natural patient walking
conditions nor is fully accessible in every vascular clinic. The widespread
availability of GPS-enabled mapping systems provides new quantitative
and qualitative methods of assessing claudication.
Methods: Fifteen patients were enrolled in a prospective pilot study at
the Ottawa Hospital. Participants were identiﬁed as true claudicants by an
experienced vascular surgeon. They were then required to undertake tread-
mill testing, answer the Walking Impairment Questionnaire (a validated
measure of MWD), and report the MWD as determined by the Google
Maps-based tool at www.runningmap.com.
Results: Determination of MWD using Google Maps proved to be
more accurate and reliable than the previously validated WIQ, where pa-
tients generally under-reported their claudication distances. Not only did
Google Maps help capture the subjectivity of individual walking environ-
ments and elevations, comparisons with the gold standard treadmill testing
revealed an expected linear relationship (slope ¼ 1.03) and relatively higher
precision than the WIQ (R2 ¼ 0.566 vs 0.374). In addition, the time taken
to report MWD using Google Maps averaged 1 minute less than the WIQ.
Conclusions: Google Maps combines the objective strengths of the
treadmill test with the qualitative advantages of the WIQ, and appears to
be a promising new tool that offers an efﬁcient and reliable way to assess
MWD in claudicant patients.
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Perfusion Angiography with Indocyanine Green Fluorescence in
Patients With Critical Ischemia
Graham Roche-Nagle. Department of Vascular Surgery, Toronto General
Hospital, Toronto, Ontario, Canada
Objectives: Perfusion, or the steady state nutritive delivery of blood
to the tissue capillary bed, is vital for the survival of tissue. Accurate perfu-
sion measurement can provide important diagnostic and prognostic infor-
mation. Precise measurement of functional tissue perfusion is needed for
preventive measures, early diagnosis, and adequate treatment, especially in
the patients with peripheral vascular diseases. Higher rates of tissue salvage
not only improve the patient’s quality of life but also positively impact the
closure and healing rates of an open wound from a partial amputation or
incision. The SPY Elite System (Novadaq Technologies, Ontario, Canada;
LifeCell, Branchburg, NJ) allows perfusion evaluation by using the ﬂuores-
cent properties of indocyanine green dye. Although this technology has
been used for decades in ophthalmology, its introduction to plastic recon-
structive surgery and vascular surgery is relatively recent. It can be used in
the intraoperative or postoperative setting to visually assess superﬁcial blood
ﬂow. The indocyanine green dye is administered, and the device’s infrared
laser stimulates the ﬂuorescent properties of the dye, allowing real-time, dy-
namic images to have an angiogram-like character, making them clear and
easy to read.
Methods: We present pilot case studies (n ¼ 5), where the SPY Fluo-
rescence Imaging Device was used to determine real-time perfusion analysis
after angiographic intervention in patients with critical ischemia.
Results: These prospective case studies demonstrate feasibility and
utility of laser-assisted ﬂuorescent angiography in the periprocedure evalua-
tion of patients with critical ischemia. Qualitative and quantitative ﬂuores-
cent images provide real-time and objective assessments of pedal tissueperfusion. Laser-assisted ﬂuorescent angiography-derived peak pedal perfu-
sion and ingress slope provide objective measurements of tissue perfusion
that correlate with conventional methods using ankle-brachial indices.
Conclusions: This technology continues to see new promising appli-
cations in many areas of surgery, including colorectal surgery, surgical
oncology, and microvascular lymphedema treatment to name a few. To
date there has been a paucity of literature published on how this technology
can be used in vascular surgery. With further study, we anticipate that this
technology may be a helpful adjunct for intra-procedural decision making
and predicting wound healing capacity.
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Amputation
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Objectives: Postoperative stump pain after major lower limb amputa-
tion is a signiﬁcant impediment to the recovery of amputees. The vast ma-
jority of patients require opioid analgesics after surgery, which are
associated with opioid-related side effects. Here, we investigate whether
intraoperative placement of a peripheral nerve stump catheter, followed
by continuous infusion of local anesthetic, is as effective at pain control
as current analgesic practices. If beneﬁcial, this procedure could potentially
reduce postamputation opioid consumption and opioid-related adverse
effects.
Methods: A retrospective record review was conducted of 198 pa-
tients over a 4-year period who had undergone a major lower limb amputa-
tion for indications related to peripheral vascular disease. Postoperatively,
102 patients who received a stump catheter were compared with 96 patients
who did not. The primary outcomes of this study were the amount of
morphine equivalents used in the ﬁrst 72 hours postoperatively and postop-
erative pain intensity in the ﬁrst 24 hours.
Results: A total of 198 lower-limb amputations were selected for an-
alyses. Multiple regression analyses indicated that perineural catheter use
was associated with a lower cumulative postoperative opioid consumption
over the ﬁrst 72 hours but not postoperative pain scores at 24 hours. Stump
catheter use led to a 40% reduction in opioid use during the ﬁrst 72 hours
postoperatively. Mixed-model repeated-measures analysis demonstrated
that this opioid reduction was consistent over time. Other variables related
to total opioid use included age, presurgical chronic pain, presurgical opioid
use, and patient controlled analgesia.
Conclusions: Continuous stump infusions of local anesthetic are a
safe and effective method for reducing postamputation opioid analgesic
medications after major lower limp amputation.
Author Disclosures: O. Ayling: Nothing to disclose. J. Montbriand:
Nothing to disclose. J. Jiang: Nothing to disclose. S. Ladak: Nothing to
disclose. L. Love: Nothing to disclose. N. Eisenberg: Nothing to disclose.
J. Katz: Nothing to disclose. H. Clarke: Nothing to disclose. G. Roche-
Nagle: Consultant, Cook, Cordis, Vascutek.
Limb-Sparing Surgery With Vascular Reconstruction for Malignant
Lower Extremity Soft Tissue Sarcoma
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Objectives: The aim of the current study was to evaluate the clinical
outcome of patients requiring vascular reconstruction in limb-sparing sur-
gery during treatment for lower extremity soft tissue sarcoma (STS).
Methods: A total of 274 patients were diagnosed with malignant
lower extremity STS between 2005 and 2013 and underwent medical man-
agement (n ¼ 3), limb-sparing surgery without vascular reconstruction (n ¼
262), and limb-sparing surgery with vascular reconstruction (n ¼ 9). Clinic
notes, intraoperative records, and follow-up visits with functional status and
quality of life questionnaires were reviewed.
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lower extremity STS underwent surgical resection with vascular reconstruc-
tion. Of these, 6 (67%) underwent resection of femoral and popliteal vessels
with subsequent femoropopliteal bypass, 1 (11%) underwent resection of
femoral vessels with iliac-SFA bypass, 1 (11%) underwent transection of
the femoral and popliteal vessels with reanastomosis, and 1 (11%) under-
went resection of the superﬁcial femoral vessels with superﬁcial femoral ar-
tery-distal superﬁcial femoral artery bypass. All bypasses were performed
using saphenous vein from the contralateral leg. Four patients (44%)
returned to the operating room for wound complications requiring incision
and drainage. Three (33%) required plastic surgery each for one of the
following: VRAM ﬂap, split-thickness skin graft, and pedicle gracilis ﬂap.
Functional activity was assessed using the criterion 1 of the Musculoskeletal
Tumor Society (MSTS) functional assessment forms preoperatively and at
follow-up at 6 months and 1 year. A score of 5 indicates no functional re-
strictions, whereas a score of 0 indicates total disability. The mean MSTS
scores preoperatively and at 6 months and 1 year were 4.1, 3.6, and 3.8,
respectively, for the vascular reconstruction group, and 4.2, 4.3, and 4.3,
respectively, for the limb-sparing surgery without vascular reconstruction
group.
Conclusions: The need for vascular reconstruction during limb-
sparing surgery for lower extremity malignant STS is rare in a high-volume
sarcoma center. Wound morbidity is high, and these patients frequently
require plastic surgery to achieve wound healing. Postoperative functional
status as assessed by the MSTS is acceptable but may be lower than in pa-
tients not requiring vascular reconstruction.
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Determining the Toe-Brachial Index in Young Healthy Adults
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Vancouver, British Columbia, Canada
Objectives: The purpose of this study was to determine the toe-
brachial index (TBI) in healthy young adults and compare it with the
accepted reference range.
Methods: Medical students from the undergraduate class were pro-
spectively recruited. Physical measurements (height, weight), health behav-
iors (physical activity quantity and type, smoking status, alcohol
consumption), and medical history (medications, relevant diagnoses, family
history) were collected. Bilateral brachial, toe, and ankle blood pressures
(using both dorsalis pedis and posterior tibial arteries) were measured.
TBI was calculated as the mean toe blood pressure divided by the highest
systolic brachial blood pressure.
Results: Forty medical students with a mean age of 24.7 6 2.1 years,
without any comorbid conditions, were studied. There were no current or
past smokers. Participants maintained relatively healthy lifestyles (hours of
activity per week: 5.1 6 3.3; body mass index: 21.7 6 2.4 kg/m2). Caffeine
and alcohol consumption was modest (10.6 6 8.5 and 1.8 6 2.7 drinks per
week, respectively). The mean systolic brachial blood pressure was 121 6
9 mm Hg (right), and 116 6 9 mm Hg (left). The TBI was 0.95 6 0.11
(right) and 0.97 6 0.13 (left) for men, and 0.86 6 0.13 (right) and 0.86
6 0.20 (left) for women.
Conclusions: The distribution of TBI in this healthy population dif-
fers signiﬁcantly from the referenced normal range of 0.6 to 1.0. Our ﬁnd-
ings suggest that the accepted value of 0.6 for the low-normal limit is too
low. This level may promote underdiagnosis of peripheral vascular disease
and represent foregone opportunities for early intervention. We recommend
that the TBI reference range be modiﬁed to increase the clinical utility of
this measurement.
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Fistula Outcomes in Octogenarians: Is a Fistula First Approach
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Vancouver, British Columbia, Canada*Principal Investigator.Objectives: The fastest growing segment of the dialysis population in
Canada is in patients aged >75 years, with an overall increase from 5% in
1980 to 28.2% in 2010. These patients present multiple signiﬁcant chal-
lenges to caregivers, including differences in life expectancy, comorbid
health status, goals of care, and supportive care requirements. The current
National Kidney Foundation Kidney Disease Outcomes Quality Initiative
guidelines do not take age into account in recommendations for hemodial-
ysis access. The goal of our study was to compare failure to mature, overall
survival, and complication rates for arteriovenous ﬁstulae in octogenarians
with nonoctogenarians to determine if our standard approach to renal access
should be modiﬁed to account for advanced age.
Methods: A review was conducted of all patients requiring arteriove-
nous ﬁstulae for hemodialysis access at two teaching hospitals between 2007
and 2012. The study was designed as a retrospective cohort study with pa-
tients stratiﬁed by age into octogenarians and nonoctogenarians. Data were
collected from a large, prospectively maintained database of all dialysis and
predialysis patients.
Results: Of 1019 patients who had their access created during the study
period andwere eligible for inclusion, 156 (15.3%) were aged$80 years at the
time of ﬁstula creation.With respect to the primary end point, therewas no dif-
ference betweenoctogenarians andnonoctogenarianswith respect to failure to
mature of the ﬁstula (38.7% vs 34.0%; P¼NS). Octogenarians had decreased
overall survival andwere signiﬁcantlymore likely to die during the study period
(45.8% vs 23.2%; P< .001). There were no signiﬁcant differences between the
two cohorts with respect to postoperative incidence of steal syndrome (7.3% vs
6.3%; P ¼ NS) or wound complications (5.3% vs 5.7%; P ¼ NS).
Conclusions: The results of this study demonstrate no overall differ-
ences in maturation rates within the octogenarian group and that age alone
should not preclude placement of an autogenous arteriovenous ﬁstula in this
cohort. These ﬁndings demonstrate that an approach that incorporates
limited life expectancy should be used when planning hemoaccess in this
growing demographic.
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Suggestion of Better Outcomes With Two-Stage Brachiobasilic Vein
Transposition: A Meta-Analysis
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Objectives: Brachiobasilic vein transposition is recommended in pa-
tients who are not candidates for a radial or brachial artery-to-cephalic
vein ﬁstula for dialysis access. One-stage and two-stage procedures both
have advantages and disadvantages. Which procedure results in improved
outcomes remains unclear.
Methods: A systematic review was conducted of the MEDLINE and
EMBASE databases for studies that compared one-stage and two-stage bra-
chiobasilic vein transpositions. Abstracts and full texts of studies were
screened independently by two reviewers, with data abstraction done in
duplicate. Random-effects meta-analysis was used to identify differences in
primary failure rates and 1-year primary and secondary patency rates. Study
quality was assessed using a previously described tool designed for observa-
tional studies reporting on dialysis access outcomes.
Results: Of 1662 abstracts that were screened, 131 were selected for
full-text review.Of these, seven studies (one randomized trial, six observational
studies) involving 737 patients met the inclusion criteria. The pooled odds ra-
tio (OR) estimate for primary failure was 1.36 (95% conﬁdence interval [CI],
0.92-2.00), suggesting reduced failure rate in patients having undergone two-
stage transpositions, although thiswas not statistically signiﬁcant (Fig 1). Simi-
larly the estimated ORs of 1.71 (95% CI, 0.89-3.28) for the 1-year primary
patency rate and 1.44 (95% CI, 0.49-4.24) for the 1-year secondary patency
rate were in favor of the two-stage procedure, but again, the results were
nonsigniﬁcant (Fig 2). Study quality was limited by unclear outcome deﬁni-
tions,minimal control for confounding, and variable selection criteria. The de-
cision topursue one-stage vs two-stagewas often basedon the size of the basilic
vein, with a two-stage procedure reserved for patients with smaller veins.
Conclusions: Meta-analysis of the existing literature comparing one-
stage and two-stage brachiobasilic vein transposition suggests improved 1-
year patency and reduced primary failure rates in the two-stage group,
despite the two-stage procedure being used in patients with smaller basilic
veins. These ﬁndings are limited by the small size, observational design,
and inconsistent quality of included studies.
